Karp Capital Management Corp Akero Therapeutics, Inc. Call Options Transaction History
Karp Capital Management Corp
- $0
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
196Shares Held
74.9MCall Options Held
210KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.38MShares$363 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$338 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$297 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$275 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$258 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.29B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...